Series D - Quanterix

Series D - Quanterix

Investment Firm

Overview

Quanterix is a biotechnology company that develops ultrasensitive biomarker detection for healthcare.

Announced Date

Mar 23, 2016

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Cormorant Asset Management

Cormorant Asset Management

Cormorant Asset Management is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

6

Investor Name
Participant InvestorCormorant Asset Management
Participant InvestorTufts University
Participant InvestorHercules Capital
Participant InvestorBain Capital Ventures
Participant InvestorARCH Venture Partners

Round Details and Background

Quanterix raised $46000000 on 2016-03-23 in Series D

Quanterix is a biotechnology company that develops ultrasensitive biomarker detection for healthcare.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 06, 2012
Debt Financing - Quanterix
-2.0M
Nov 15, 2012
Series C - Quanterix
5-18.5M
Aug 19, 2011
Series B - Quanterix
1-6.0M
Aug 25, 2008
Series A - Quanterix
3-15.0M

Recent Activity

There is no recent news or activity for this profile.